A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer

INTRODUCTION: Immunotherapy has become the standard of care in advanced non-small cell lung cancer (NSCLC). We aimed to quantify the economic impact, in France, of anti-PD-1 therapy for NSCLC. METHODS: We used patient-level data from the national ESCAP-2011-CPHG cohort study to estimate time to trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Legoupil, Clémence, Debieuvre, Didier, Marabelle, Aurelien, Michiels, Stefan, Kapso, Raïssa, Besse, Benjamin, Bonastre, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167209/
https://www.ncbi.nlm.nih.gov/pubmed/32337213
http://dx.doi.org/10.1183/23120541.00174-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167209/
https://www.ncbi.nlm.nih.gov/pubmed/32337213
http://dx.doi.org/10.1183/23120541.00174-2019

Ejemplares similares